Home Research Reports Technological Advancements in Clinical Trials and Therapies to hold the Hopes high for Cancer Treatment
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Technological Advancements in Clinical Trials and Therapies to hold the Hopes high for Cancer Treatment

by gbaf

There has been no looking back for clinical trial management system with higher occurrences of chronic diseases across the globe. In other words, the frequency of clinical trials has witnessed an exponentiation in the last few years with sternness pertaining to enforcing clinical trial registration. Deployment-wise, it’s on-site and enterprise-wise. By delivery, it’s cloud-based (SaaS), licensed enterprise (on-premises), and web-based (on-demand). Based on products & services, it’s services and software. End-user-wise, it’s CROs, large pharma-biotech companies, medical device manufacturers, small & mid-sized pharma-biotech companies, and others.

Coming to membrane technology market, it is being pushed by extensive research activities in biopharmaceuticals, pharmaceuticals, food industry, and life sciences across the globe. Technology-wise, it’s chromatography, ultrafiltration, microfiltration, nanofiltration, reverse osmosis, and electrodialysis. Membrane techniques come across as highly advanced ones and make way for precise results.

Home infusion therapy has been doing the rounds, especially after the outbreak of Covid-19. It has been reported that home infusion therapy works wonders with regards to taking care of people suffering from chronic ailments like asthma, diabetes, cancer, obesity, and may others. B Braun Melsungen, in April 2020, did receive EUA (Emergency Use Authorization) from the US FDA for using infusion pump along with nebulizers for treating Covid-19-affected patients. Product-wise, home infusion therapy comprises intravenous sets, infusion pumps, IV cannulas, and needleless connectors. Application-wise, they constitute parenteral nutrition, enteral nutrition, chemotherapy, hydration therapy, anti-infective, and specialty pharmaceuticals.

Regarding cancer treatment, immunooncology is amongst the most trustworthy courses of treatment. By type of therapy, it could be categorized as immune checkpoint inhibitors (CTLA-4, PD-L1, and PD-1), immune system modulators, cancer vaccines, oncolytic virus, and others (immune cell therapy). Based on therapeutic area, it spans blood cancers, lung cancer, melanoma, renal cell carcinoma, prostate cancer, bladder cancer, and others.

DNA and RNA sample preparation is picking up as it does pave the way for accessibility to the nucleic acids, that too, in natural form and does away with contaminants. RNA interference (RNAi) is a new-fangled scientific investigation herein. Also, in wake of the ongoing pandemic, Covaris, Inc., in February 2020, did launch 1 novel kits to facilitate viral RNA extraction from throat or nasal swab sample collection devices including truXTRAC-PCR Direct Viral RNA Extraction Kit and truXTRAC Viral RNA Extraction Kit by making use of Puritan Swabs.

Endoscopes are increasingly used for viewing internal cavities of the human body. Inert materials like polyurethane is preferred for making endoscopes. Polyurethane does resist corrosion with respect to bodily fluids. Endoscope repair and maintenance are inevitable as frequency of diagnosis of chronic diseases like cancers along with checking infection of genitourinary and gastrointestinal tract are bound to increase in the upcoming period.

Endoscopic mucosal resection, based on product, spans lift-and-cut technique and suck-and-cut technique. Based on end-user, it could be ASCs (Ambulatory Surgical Centers), hospitals, and others. Diagnosis-wise, it could be esophageal cancer, stomach cancer, duodenal cancer, and colon cancer.

As far as operating tables are concerned, the mobile versions of the same are being asked for these days. The mobile operating tables imply movable tables used for laying down patients at the time of surgical procedures so that hassle-free surgeries could take place (with space as well as time management).

Human microbiome implies a constellation of micro-organisms residing on the layers of skin, and also in conjunctiva, saliva, GIT (gastrointestinal tract), and oral mucosa. They could be fungi, archea, and bacteria. In line with researchers emphasizing on enhancing efficiency of the therapeutic course consisting of subset of the micro-organisms known as Endoscopic Mucosal Resection. Players like Enterome has its diagnostic tool to detect inflammatory bowel disease by making use of genetic sequencing platform. The other application areas include diabetes, multiple sclerosis, rheumatoid arthritis, and likewise.

Huber needles play a vital role in withdrawal of blood and infusing medication, nutritional solutions, and blood products through a port that is implanted in a patient who is chronically ill. By type, they are straight Huber needles and curved Huber needles. Application-wise, they are IV cancer application, blood transfusions, dialysis, home parenteral nutrition, lap-band adjustments, and others).

The key participants captured by Persistence Market Research (PMR) include:

  • Advarraa technology Solutions
  • ArisGlobal
  • Bioclinica
  • Medidata Solutions
  • Oracle Corporation
  • Bio-Optronics
  • Parexel International
  • Veeva Systems
  • 3M Healthcare
  • Merck Millipore
  • Pall Corporation
  • Koch Membrane Systems
  • Baxter International, Inc.
  • Amgen, Inc.
  • AstraZeneca Plc
  • Miroculus
  • Associated Endoscopy
  • Endodoctor
  • Olympus
  • Cook Medical Inc.
  • Enterome Bioscience
  • MicroBiome Therapeutics LLC
  • Pfizer

Cancer is something that has been gripping the world at large. Persistence Market Research (PMR) has put forth the therapeutic ways and the instruments to assist the same.

You may also like